PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

In CRISPR advance, scientists successfully edit human T cells

Research has implications for autoimmune diseases, AIDS, and cancer

2015-07-27
(Press-News.org) In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9. Because these immune-system cells play important roles in a wide range of diseases, from diabetes to AIDS to cancer, the achievement provides a versatile new tool for research on T cell function, as well as a path toward CRISPR/Cas9-based therapies for many serious health problems.

Using their novel approach, the scientists were able to disable a protein on the T-cell surface called CXCR4, which can be exploited by HIV when the virus infects T cells and causes AIDS. The group also successfully shut down PD-1, a protein that has attracted intense interest in the burgeoning field of cancer immunotherapy, as scientists have shown that using drugs to block PD-1 coaxes T cells to attack tumors.

The CRISPR/Cas9 system has captured the imagination of both scientists and the general public, because it makes it possible to easily and inexpensively edit genetic information in virtually any organism. T cells, which circulate in the blood, are an obvious candidate for medical applications of the technology, as these cells not only stand at the center of many disease processes, but could be easily gathered from patients, edited with CRISPR/Cas9, then returned to the body to exert therapeutic effects.

But in practice, editing T cell genomes with CRISPR/Cas9 has proved surprisingly difficult, said Alexander Marson, PhD, a UCSF Sandler Fellow, and senior and co-corresponding author of the new study. "Genome editing in human T cells has been a notable challenge for the field," Marson said. "So we spent the past year and a half trying to optimize editing in functional T cells. There are a lot of potential therapeutic applications, and we want to make sure we're driving this as hard as we can."

The new work was done under the auspices of the Innovative Genomics Initiative (IGI), a joint UC Berkeley-UCSF program co-directed by Berkeley's Jennifer Doudna, PhD, who is world-renowned for her pioneering research on CRISPR/Cas9, and Jonathan Weissman, PhD, professor of cellular and molecular pharmacology at UCSF and a Howard Hughes Medical Institute (HHMI) investigator. Marson is an affiliate member of the IGI.

Doudna, professor of chemistry and of cell and molecular biology at Berkeley, and an HHMI investigator, said that the research is a significant step forward in bringing the power of CRISPR/Cas9 editing to human biology and medicine. "It's been great to be part of this exciting collaboration, and I look forward to seeing the insights from this work used to help patients in the future," said Doudna, co-corresponding author of the new paper.

Cas9, an enzyme in the CRISPR system that makes cuts in DNA and allows new genetic sequences to be inserted, has generally been introduced into cells using viruses or circular bits of DNA called plasmids. Then, in a separate step, a genetic construct known as single-guide RNA, which steers Cas9 to the specific spots in DNA where cuts are desired, is also placed into the cells.

Until recently, however, editing human T cells with CRISPR/Cas9 has been inefficient, with only a relatively small percentage of cells being successfully modified. And while scientists have had some success in switching off genes by inserting or deleting random sequences, they have not yet been able to use CRISPR/Cas9 to paste in (or "knock in") specific new sequences to correct mutations in T cells.

As will be reported online in Proceedings of the National Academy of Sciences during the week of July 27, 2015, a team led by first authors Kathrin Schumann, PhD, a postdoctoral fellow in Marson's laboratory, and Steven Lin, PhD, a postdoctoral fellow in the Doudna lab, cracked these problems by streamlining the delivery of Cas9 and single-guide RNA to cells.

In lab dishes, the group assembled Cas9 ribonucleoproteins, or RNPs, which combine the Cas9 protein with single-guide RNA. They then used a method known as electroporation, in which cells are briefly exposed to an electrical field that makes their membranes more permeable, to quickly deliver these RNPs to the interior of the cells.

With these innovations, the researchers successfully edited CXCR4 and PD-1, even knocking in new sequences to replace specific genetic "letters" in these proteins. The group was then able to sort the cells using markers expressed on the cell surface, to help pull out successfully edited cells for research, and eventually for therapeutic use.

"We tried for a long time to introduce Cas9 with plasmids or lentiviruses, and then to express separately the single-guide RNA in the cell," Schumann said. "Using RNPs made outside the cell, so that the cell is responsible for as little of the process as possible, has made a big difference."

Marson stressed that, while recent reports of CRISPR/Cas9 editing of human embryos have stirred up controversy, T cells are created anew in each individual, so modifications would not be passed on to future generations. He hopes that Cas9-based therapies for T cell-related disorders, which include autoimmune diseases as well as immunodeficiencies such as "bubble boy disease," will enter the clinic in the future.

"There's actually well-trodden ground putting modified T cells into patients. There are companies out there already doing it and figuring out the safety profile, so there's increasing clinical infrastructure that we could potentially piggyback on as we work out more details of genome editing," Marson said. "I think CRISPR-edited T cells will eventually go into patients, and it would be wrong not to think about the steps we need to take to get there safely and effectively."

INFORMATION:

Other UCSF researchers participating in the study were Eric Boyer, staff research assistant; graduate students Dimitre R. Simeonov and Meena Subramaniam; research technician Rachel E. Gate; postdoctoral fellow Genevieve E. Haliburton, PhD; Chun Ye, PhD, assistant professor of epidemiology and biostatistics; and Jeffrey A. Bluestone, PhD, the A.W. and Mary Margaret Clausen Distinguished Professor in Metabolism and Endocrinology.

The research was supported by a gift from Jake Aronov, and by the UCSF Sandler Fellows Program; the National Institutes of Health; the National MS Society; and the Howard Hughes Medical Institute.



ELSE PRESS RELEASES FROM THIS DATE:

Gene therapy may improve survival of patients with recurrent ovarian cancer

2015-07-27
Use of gene therapy to deliver a protein that suppresses the development of female reproductive organs may improve the survival of patients with ovarian cancer that has recurred after chemotherapy, which happens 70 percent of the time and is invariably fatal. In their report receiving online publication in PNAS Early Edition, a Massachusetts General Hospital (MGH) research team describes how a single injection of a modified version of Mullerian Inhibiting Substance, a protein critical to sexual development, carried on a commonly used viral vector suppressed the growth ...

Narrowing in on pituitary tumors

2015-07-27
As many as 20 percent of people may have a benign cyst or tumor in their pituitary gland. The vast majority of pituitary tumors are noncancerous, but can cause headaches and profound fatigue, and can also disrupt hormone function. Currently, surgeons rely on radiologic images and MRIs to gather information about the size and shape of the tumor, but the resolution of such imaging technologies is limited, and additional surgeries to remove more of the tumor may be needed if a patient's symptoms persist. In a new study published in the Proceedings of the National Academy ...

Greenhouse gas source underestimated from the US Corn Belt, University of Minnesota-led study shows

2015-07-27
Estimates of how much nitrous oxide, a significant greenhouse gas and stratospheric ozone-depleting substance, is being emitted in the central United States have been too low by as much as 40 percent, a new study led by University of Minnesota scientists shows. The study, published today in the journal Proceedings of the National Academy of Sciences, measured how much nitrous oxide is emitted from streams in an agriculturally dense area in southern Minnesota. Agriculture, and specifically nitrogen fertilizers used in row-crop farming, is a major contributor to nitrous ...

Mobile stroke treatment units may greatly improve survival rates, chance of recovery for ischemic stroke patients

2015-07-27
SAN FRANCISCO, CALIF. - July 27, 2015 - Two new studies presented today at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, report that Mobile Stroke Treatment Units (MSTUs) can significantly reduce the time it takes to diagnose and treat patients for stroke, greatly improving survival rates and enhancing a patient's chance of recovery. There are currently four MSTUs in use worldwide. Two are in Germany and two are in the United States (U.S.) - one in Cleveland and one in Houston. MSTUs resemble ambulances on the outside, but contain ...

Compulsory schooling laws could bolster free community college argument

2015-07-27
LAWRENCE -- Providing two years of free community college to qualifying students is expected to be a hot topic during the 2016 presidential campaign. President Barack Obama introduced the plan earlier this year, aimed at boosting educational attainment and workforce opportunities of thousands of students -- especially those from low-income families. Support for expanded education is not the purview of one party, however; President George W. Bush also frequently referenced the significance of two-year colleges. Tennessee and Oregon are offering free community college to ...

UW study shows how a kernel got naked and corn became king

UW study shows how a kernel got naked and corn became king
2015-07-27
MADISON, Wis. - Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet. Now, University of Wisconsin-Madison researchers have found that just a single letter change in the genetic script of corn's ancestor, teosinte, helped make it all possible. Publishing in the journal Genetics this month, UW-Madison professor John Doebley and a team of researchers describe how, during the domestication of corn, a single nucleotide change in the teosinte glume architectural gene (tga1) stripped ...

Improved survival of HIV patients facilitates heart disease research

2015-07-27
WASHINGTON (July 27, 2015) - The improved survival rate of HIV patients in sub-Saharan Africa due to effective treatment programs is increasing the ability of researchers in Africa to study the impacts of cardiovascular disease in HIV patients, according to a guest editor page published today in the Journal of the American College of Cardiology. According to guest editor Pravin Manga, M.B.B.C.H., Ph.D., of the University of Witwatersrand in Johannesburg, some countries in sub-Saharan Africa, like South Africa, have created highly active antiretroviral treatment programs ...

Some vaccines support evolution of more-virulent viruses

2015-07-27
Scientific experiments with the herpes virus strain that causes Marek's disease in poultry have confirmed, for the first time, the highly controversial theory that some types of vaccines allow for the evolution and survival of increasingly virulent versions of a virus, putting unvaccinated individuals at greater risk of severe illness. The research has important implications for food-chain security and food-chain economics, as well as for other diseases that affect humans and agricultural animals. The new research, which will be published in the Open Access journal PLOS ...

Some stroke treatments proven to reduce health care costs

2015-07-27
SAN FRANCISCO, CALIF. - July 27, 2015 - Use of mechanical thrombectomy on qualifying stroke patients could result in major savings to the healthcare economy in the United Kingdom (U.K.) and other western countries with a similar healthcare structure, according to a new study presented at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco. The study, Developing an Interventional Stroke Service: Improving Clinical Outcomes and Reducing Cost and Delivering Great Cost Savings Benefits to Health Economy, conducted at the University Hospital of ...

Researchers uncover blood markers to identify women at risk for postpartum depression

2015-07-27
Postpartum depression is a debilitating disorder that affects nearly 20 percent of new mothers, putting their infants at increased risk for poor behavioral, cognitive and social development. Researchers know that the hormone oxytocin, which plays a positive role in healthy birth, maternal bonding, relationships, lower stress levels, mood and emotional regulation, also is associated with postpartum depression when a mother has lower levels of the hormone. A University of Virginia researcher and a team from several institutions in the United States and England have now ...

LAST 30 PRESS RELEASES:

Plant doctor: An AI system that watches over urban trees without touching a leaf

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

[Press-News.org] In CRISPR advance, scientists successfully edit human T cells
Research has implications for autoimmune diseases, AIDS, and cancer